Regeneron drug tames eczema in study

PARIS/NEW YORK (Reuters) - An experimental drug from Sanofi and Regeneron Pharmaceuticals Inc significantly reduced skin lesions and itching in adult patients with atopic dermatitis, a chronic form of eczema that is poorly controlled by standard drugs, the companies said on Wednesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news